Journals / Eurasian Journal of Pulmonology / 2019 / Cilt: 21 - Sayı: 2

Evaluation of ghrelin and leptin in chronic obstructive pulmonary disease

Pages
114–121
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Decreased ghrelin and leptinlevels might be associated with the development of obstruction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Recent studies suggest an important role for ghrelin and leptin in pathogenesis ofinflammatory respiratory diseases.
📊
Key Findings & Data:Therefore, the present study aimed to investigate ghrelin andleptin levels in the circulation that might be associated with the development of obstruction.METHODS: Stable chronic obstructive pulmonary disease (COPD) patients (n = 119) and matchedhealthy controls (n = 27) were recruited.
💡
Conclusion & Impact:Decreased ghrelin and leptinlevels might be associated with the development of obstruction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Recent studies suggest an important role for ghrelin and leptin in pathogenesis ofinflammatory respiratory diseases. Therefore, the present study aimed to investigate ghrelin andleptin levels in the circulation that might be associated with the development of obstruction.METHODS: Stable chronic obstructive pulmonary disease (COPD) patients (n = 119) and matchedhealthy controls (n = 27) were recruited. The COPD patients were classified into four groups (A, B,C, and D) according to the Revised Global Initiative for Chronic Obstructive Lung Disease guidelines.RESULTS: Compared to controls, significantly decreased leptin and ghrelin levels were observedin all COPD patient groups. Plasma ghrelin concentration was higher in Group A (P < 0.001),Group B (P < 0.001), and Group C (P < 0.05) when compared with the Group D. Plasmaleptin concentration was significantly decreased in Group D patients when compared withGroup A (P < 0.001) and Group B (P < 0.001). Ghrelin levels were positively correlated with forcedexpiratory volume in 1 s (FEV1) (r = 0.822; P < 0.001), FEV1/forced vital capacity (FVC) (r = 0.431;P < 0.01), and leptin (r = 0.808; P < 0.001) in Group D. Leptin showed positive correlation withFEV1 (r = 0.856; P < 0.001) and FEV1/FVC (r = 0.376; P < 0.05) in Group D. FEV1 was positivelycorrelated with ghrelin levels (r = 0.639; P < 0.001) and leptin levels (r = 0.602; P < 0.001) in Group C.CONCLUSION: The data of the present study showed that the serum ghrelin and leptin levels arelower in patients with COPD. Since ghrelin and leptin correlate with FEV1 in severe group of patients,they seem to be a potential biomarker candidate of prognosis in COPD. Decreased ghrelin and leptinlevels might be associated with the development of obstruction.

🔖

Cite This Article

UYSAL, P., UZUN, H. (2022). Evaluation of ghrelin and leptin in chronic obstructive pulmonary disease. Eurasian Journal of Pulmonology, Cilt: 21 - Sayı: 2, 114–121. https://ajindex.com/articles/509636

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease; 2011. Available from: http:// www.goldcopd.org. [Last accessed on 2013 Oct 10]
  2. Erdinç E, Polatlı M, Kocabaş A, Yıldırım N, Gürgün A, Saryal S, et al. Turkish Thoracic Society; Chronic obstructive pulmonary disease diagnosis and treatment consensus report (Article in Turkish). Turkish Thoracic J 2010;11(Suppl 1):1-64
  3. Itoh T, Nagaya N, Yoshikawa M, Fukuoka A, Takenaka H, Shimizu Y, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:879‑82
  4. Özkan S, Çaylak E. Ghrelin and its biochemical functions: Review. Turkiye Klinikleri J Med Sci 2006;26:272-83
  5. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194‑8
  6. Colldén G, Tschöp MH, Müller TD. Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci 2017;18. pii: E798
  7. Wang Y, Shen Y, Zuo Q, Zhao L, Wan C, Tian P, et al. Evaluation of ghrelin level and appetite regulation in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:863‑70
  8. Uzum AK, Aydin MM, Tutuncu Y, Omer B, Kiyan E, Alagol F, et al. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight chronic obstructive pulmonary disease patients. Eur J Intern Med 2014;25:364‑9
  9. Xu ZS, Bao ZY, Wang ZY, Yang GJ, Zhu DF, Zhang L, et al. The changes of ghrelin, growth hormone, growth hormone releasing hormone and their clinical significances in patients with chronic obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi 2012;51:536‑9
  10. Peng M, Cai BQ, Ma Y, Zhu HJ, Sun Q, Song AL, et al. Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2007;30:182‑5
  11. Ying BW, Song XB, Fan H, Wang LL, Li YS, Cheng Z, et al. Plasma ghrelin levels and weight loss in Chinese Uygur patients with chronic obstructive pulmonary disease. J Int Med Res 2008;36:1371‑7
  12. Piehl‑Aulin K, Jones I, Lindvall B, Magnuson A, Abdel‑Halim SM. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary diseas